Screener
CapEx at other companies
Other financials
Where this comes from
Reported directly by Ionis Pharmaceuticals in its filing.
Tagged under the XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment.
The source filing: Ionis Pharmaceuticals’s 10-Q, filed July 29, 2026.
- Filed
- Jul 29, 2026, 5:05 PM EDT
- Fiscal quarter
- Q2 FY2026
- Calendar quarter
- Q2 2026
- Accession
- 0000874015-26-000251
| Line item | Six Months Ended / June 30, 2026 | Six Months Ended / June 30, 2025 |
|---|---|---|
| Investing activities: | ||
| Purchases of short-term investments | (513,005) | (802,657) |
| Proceeds from sale of short-term investments | 1,114,805 | 880,545 |
| Purchases of property, plant and equipment | (37,843) | (24,882) |
| Acquisition of licenses and other assets, net | (3,640) | (2,615) |
| Net cash provided by investing activities | 560,317 | 50,391 |
| Financing activities: | ||
| Proceeds from issuance of common stock through equity plans, net | 77,560 | 3,528 |
ITEM 1. FINANCIAL STATEMENTS
FAQ
- What is Ionis Pharmaceuticals's capex?
- Ionis Pharmaceuticals (IONS) reported capex of $16.08M in Q2 2026.
- How has Ionis Pharmaceuticals's capex changed year-over-year?
- Ionis Pharmaceuticals's capex increased by 30.7% year-over-year, from $12.31M to $16.08M.
- What is the long-term trend for Ionis Pharmaceuticals's capex?
- Over 4 years (2021 to 2025), Ionis Pharmaceuticals's capex has grown at a 44.0% compound annual growth rate (CAGR), from $11.96M to $51.44M.
- What does capex mean?
- Cash spent on property, plant, and equipment — the primary measure of investment in productive capacity and infrastructure.
Ask your AI about Ionis Pharmaceuticals's capex.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude